STOP2030 at the Annual NTD Programme Manager Meeting: STH innovation in focus
Several members of the STOP2030 consortium participated in the 2026 [...]
Ghana FDA approves the fixed-dose coformulation of ivermectin and albendazole
In the last days of December 2025, the Ghana Food [...]
The REALISE clinical begins sample collection and dosing
Our latest clinical trial has started its clinical phase as sample collection and dosing started in Kenya
With the Site Initiation Visit Complete, Our Team Prepares to Launch the REALISE Study
The Ghana Health Service (GHS) Research and Development Division, along [...]
EMA adopts positive scientific opinion on our ivermectin/albendazole fixed-dose coformulation
The STOP2030 Consortium is pleased to announce that the Committee [...]
Our latest popPK study supports the dosing strategy of our ivermectin/albendazole FDC
A new paper on the population pharmacokinetics (PK) of our [...]
Innovating a 50-Year-Old Drug: The Fixed-Dose Ivermectin Approach
The quest to find optimal treatment strategies for Neglected [...]
STOP2030 Consortium Gathers in Nairobi to Plan Steps Towards the Finish Line
On June 5-6, the seven partner organizations within the STOP2030 [...]
Collins Okoyo earned his PhD by modelling the best strategies for the elimination of STH
We are happy to announce that Collins Okoyo, the STOP2030’s [...]
